Clinical Trials · NCT07588438
Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Las Rías Medical Center
- Enrollment
- 160
- Start date
- Jul 2026
- Locations
- 1 site, Paraguay
- Primary endpoint
- Mean Percent Change From Baseline in Body Weight at 52 Weeks.